Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

KPV dosage comparison table

Here's a quick reference comparing dosing across different forms and conditions: Administration Method Condition Low Dose Moderate Dose High Dose Frequency Duration Injectable SubQ Gut inflammation 500mcg 1,000mcg 1,500mcg Once daily 8-12 weeks Skin conditions

This comparison does not assign a generated winner or score.

  • Here's a quick reference comparing dosing across different forms and conditions:
  • Administration Method
  • Condition
  • Low Dose
  • Moderate Dose
  • High Dose
  • Frequency
  • Duration
  • Injectable SubQ
  • Gut inflammation
  • 500mcg
  • 1,000mcg
  • 1,500mcg
  • Once daily
  • 8-12 weeks
  • Skin conditions
  • 8-16 weeks
  • General anti-inflammatory
  • N/A
  • Ongoing
  • Oral capsules
  • IBD/Crohn's/UC
  • 2,000-3,000mcg
  • 1-2x daily
  • Leaky gut
  • 6-12 weeks
  • General support
  • Nasal spray
  • 500-750mcg
  • 1,000-1,500mcg
  • 2,000mcg
  • 2x daily
  • 4-8 weeks
  • Topical cream
  • Eczema/psoriasis
  • 1% cream 2x daily
  • 2% cream 2x daily
  • 2% cream 3x daily
  • As directed
  • Notes:
  • Low dose = mild conditions or maintenance
  • Moderate dose = active inflammation, most common therapeutic dose
  • High dose = severe or resistant cases
  • All injectable doses are subcutaneous
  • Oral doses account for lower bioavailability
More references

Related material

Comparison

Oral vs Injectable KPV Dosing

Oral and subcutaneous KPV use the same daily milligram range. The difference is destination, not dose size. Best target Gut, IBD, colitis Systemic, joints, widespread skin Absorpt…

View details →
Comparison

Comparison: KPV vs. KPV Deep Dive

The distinction between "KPV" as a general anti-inflammatory peptide and its deep dive research context is primarily one of application specificity. While basic KPV pharmacology e…

View details →